Evaluation of anti-mutated citrullinated vimentin antibodies, anti-cyclic citrullinated peptide antibodies and rheumatoid factor in omani patients with rheumatoid arthritis

International Journal of Rheumatology

Volumn 2012, Issue , 2012, Pages

  Al Shukaili, Ahmed ^a   Al Ghafri, Saif ^b   Al Marhoobi, Safia ^a   Alkaabi, Juma ^b  

^a THE RESEARCH COUNCIL   (Oman)

^b SULTAN QABOOS UNIVERSITY   (Oman)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; RHEUMATOID FACTOR; VIMENTIN;

ADULT; ARAB; ARTICLE; CITRULLINEMIA; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNIC GROUP; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALAYSIA; MALE; NETHERLANDS; OMAN; PREDICTIVE VALUE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; TUNISIA; TURKEY (REPUBLIC);

EID: 84866184276     PISSN: 16879260     EISSN: 16879279     Source Type: Journal    
DOI: 10.1155/2012/285854     Document Type: Article

References (21)

1. Avouac J., Gossec L., Dougados M., Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review. Annals of the Rheumatic Diseases 2006 65 7 845 851 2-s2.0-33745725970 10.1136/ard.2006.051391
2. Van Venrooij W. J., Van Beers J. J. B. C., Pruijn G. J. M., Anti-CCP antibodies: the past, the present and the future. Nature Reviews Rheumatology 2011 7 7 391 398 2-s2.0-79959922908 10.1038/nrrheum.2011.76
3. Schoels M., Bombardier C., Aletaha D., Diagnostic and prognostic value of antibodies and soluble biomarkers in undifferentiated peripheral inflammatory arthritis: a systematic review. Journal of Rheumatology 2011 38 87 20 25 2-s2.0-79952366330 10.3899/jrheum.101070
4. Bizzaro N., The predictive significance of autoantibodies in organ-specific autoimmune diseases. Clinical Reviews in Allergy and Immunology 2008 34 3 326 331 2-s2.0-49349084351 10.1007/s12016-007-8059-5
5. Poulsom H., Charles P. J., Antibodies to citrullinated vimentin are a specific and sensitive marker for the diagnosis of rheumatoid arthritis. Clinical Reviews in Allergy and Immunology 2008 34 1 4 10 2-s2.0-49349091092 10.1007/s12016-007-8016-3
6. Bang H., Egerer K., Gauliard A., Lüthke K., Rudolph P. E., Fredenhagen G., Berg W., Feist E., Burmester G. R., Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis. Arthritis & Rheumatism 2007 56 8 2503 2511 2-s2.0-34547785469 10.1002/art.22817 (Pubitemid 47237269)
7. Sghiri R., Bouajina E., Bargaoui D., Harzallah L., Fredj H. B., Sammoud S., Ghedira I., Value of anti-mutated citrullinated vimentin antibodies in diagnosing rheumatoid arthritis. Rheumatology International 2008 29 1 59 62 2-s2.0-53149087063 10.1007/s00296-008-0614-8
8. Dejaco C., Klotz W., Larcher H., Duftner C., Schirmer M., Herold M., Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis. Arthritis Research and Therapy 2006 8 4, article R119 2-s2.0-70350615912 10.1186/ar2008
9. Ursum J., Nielen M. M. J., van Schaardenburg D., van der Horst A. R., van de Stadt R. J., Dijkmans B. A. C., Hamann D., Antibodies to mutated citrullinated vimentin and disease activity score in early arthritis: a cohort study. Arthritis Research and Therapy 2008 10 1, article no. R12 2-s2.0-39549108663 10.1186/ar2362
10. Innala L., Kokkonen H., Eriksson C., Jidell E., Berglin E., Rantapää-Dahlqvist S., Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides. Journal of Rheumatology 2008 35 6 1002 1008 2-s2.0-44949142258 (Pubitemid 351813144)
11. Arnett F. C., Edworthy S. M., Bloch D. A., McShane D. J., Fries J. F., Cooper N. S., Healey L. A., Kaplan S. R., Liang M. H., Luthra H. S., Medsger T. A., Mitchell D. M., Neustadt D. H., Pinals R. S., Schaller J. G., Sharp J. T., Wilder R. L., Hunder G. G., The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis & Rheumatism 1988 31 3 315 324 2-s2.0-0023945481 (Pubitemid 18091653)
12. Maraina C. H. C., Nurdayana A. K., Rusni D., Azwany Y., Diagnostic value of anti-modified citrullinated vimentin in rheumatoid arthritis. International Journal of Rheumatic Diseases 2010 13 4 335 339 2-s2.0-77958108583 10.1111/j.1756-185X.2010.01552.x
13. Liu X., Jia R., Zhao J., Li Z., The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis. Journal of Rheumatology 2009 36 6 1136 1142 2-s2.0-67149130596 10.3899/jrheum.080796
14. Bizzaro N., Antibodies to citrullinated peptides: a significant step forward in the early diagnosis of rheumatoid arthritis. Clinical Chemistry and Laboratory Medicine 2007 45 2 150 157 2-s2.0-33847121296 10.1515/CCLM.2007.027 (Pubitemid 46294678)
15. Nicaise Roland P., Grootenboer Mignot S., Bruns A., Hurtado M., Palazzo E., Hayem G., Dieudé P., Meyer O., Chollet Martin S., Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapy. Arthritis Research & Therapy 2008 10 6, article R142 2-s2.0-67949091264
16. Mathsson L., Mullazehi M., Wick M. C., Sjöberg O., Van Vollenhoven R., Klareskog L., Rönnelid J., Antibodies against citrullinated vimentin in rheumatoid arthritis: higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides. Arthritis & Rheumatism 2008 58 1 36 45 2-s2.0-38149026334 10.1002/art.23188
17. Egerer K., Bang H., Lathke K., A new powerful marker for the diagnosis and prognosis of rheumatoid arthritis: anti-MCV antibodies. Arthritis & Rheumatism 2005 52, article S118 supplement 9
18. Keskin G., Inal A., Keskin D., Pekel A., Baysal O., Dizer U., Şengül A., Diagnostic utility of anti-cyclic citrullinated peptide and anti-modified citrullinated vimentin antibodies in rheumatoid arthritis. Protein and Peptide Letters 2008 15 3 314 317 2-s2.0-41449084614 10.2174/092986608783744153 (Pubitemid 351457383)
19. Vencovsk J., Macháček S., Šedová L., Kafková J., Gatterová J., Pešáková V., Růžičková S.., Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis. Annals of the Rheumatic Diseases 2003 62 5 427 430 2-s2.0-0037404894 10.1136/ard.62.5.427 (Pubitemid 36469733)
20. Van Der Linden M. P. M., Van Der Woude D., Ioan-Facsinay A., Levarht E. W. N., Stoeken-Rijsbergen G., Huizinga T. W. J., Toes R. E. M., Van Der Helm-van Mil A. H. M., Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis. Arthritis & Rheumatism 2009 60 8 2232 2241 2-s2.0-68049104242 10.1002/art.24716
21. Mutlu N., Bicakcigil M., Tasan D. A., Kaya A., Yavuz S., Ozden A. I., Comparative performance analysis of 4 different anti-citrullinated protein assays in the diagnosis of rheumatoid arthritis. Journal of Rheumatology 2009 36 3 491 500 2-s2.0-65649151408 10.3899/jrheum.080656